
|Videos|July 16, 2021
The Potential of CAR T-Cell Therapy in Adult ALL
Author(s)Eunice Wang, MD, Bijal D. Shah, MD
Eunice Wang, MD, and Bijal Shah, MD, MS, discussed unmet needs for adult patients with relapsed/refractory ALL and reflect on the current treatment landscape.
Advertisement
This content originally appeared on our sister site,
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CGTlive®
1
CGTLive®’s Weekly Rewind – December 12, 2025
2
Around the Helix: Cell and Gene Therapy Company Updates – December 10, 2025
3
FDA Approves Waskyra as First Gene Therapy for Wiskott-Aldrich Syndrome
4
Steven W. Pipe, MD, on the End-of-Study Results From Hemgenix’s HOPE-B Trial
5


















































